Literature DB >> 12838004

Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey.

Randall P Morton1.   

Abstract

OBJECTIVES: To examine quality-of-life (QL) changes that occur over time among patients treated for head and neck cancer and to compare QL outcomes in two geographically separate and culturally distinct populations. STUDY
DESIGN: A prospective, observational longitudinal study was made of QL changes over time in head and neck cancer patients, and a matched-pairs cross-sectional study was conducted for comparison of QL outcomes between groups of head and neck cancer patients from two different sociocultural environments.
METHODS: Patients attending a tertiary head and neck cancer center in Auckland, New Zealand, were interviewed using a validated questionnaire before treatment and at 3, 12, and 24 months after treatment. Changes over time were assessed according to gender, site and stage of primary tumor, and type of treatment received. A second group of patients from Toronto, Ontario, Canada, were matched to the first group for age, gender, site and stage of tumor, and time since treatment and interviewed using the same questionnaire. The group comparison was followed by a matched-pairs analysis for the 12-month follow-up interval.
RESULTS: In the longitudinal study, combined modality treatment resulted in greater physical and somatic dysfunction than single modality treatment. Patients learned to cope well with dysfunction and disability and with adjusting their lifestyle so that overall QL was not related to treatment received. Even so, pain scores and measures of psychological distress were related to overall QL. Otherwise there was no consistent correlation between specific symptoms and QL. An illustration of patients' adaptation to dysfunction was evident in scores for perceived difficulty swallowing, which decrease despite the ongoing need for a soft or liquid diet. In the comparative study, significantly different global QL scores were evident in the two clinical groups studied, despite similar social, somatic, and physical functioning. There was also a significant but inconstant difference in emotional functioning. Although the clinical groups received significantly different treatment regimens, the observed differences in global QL were independent of treatment received.
CONCLUSIONS: Patients with head and neck cancer generally managed well despite disability and dysfunction after treatment. Patients' expectations, emotional responses, and desired outcomes seemed to be determined by sociocultural factors, causing different patient groups to view their overall QL outcome somewhat differently.

Entities:  

Mesh:

Year:  2003        PMID: 12838004     DOI: 10.1097/00005537-200307000-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas.

Authors:  H J Aarstad; A K H Aarstad; S Lybak; O Monge; D F Haugen; J Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-05       Impact factor: 2.503

Review 2.  Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature.

Authors:  Anne Marijn Kreeft; Lisette van der Molen; Frans J Hilgers; Alfons J Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11       Impact factor: 2.503

3.  Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.

Authors:  Silke Tribius; Marieclaire Raguse; Christian Voigt; Adrian Münscher; Alexander Gröbe; Cordula Petersen; Andreas Krüll; Corinna Bergelt; Susanne Singer
Journal:  Strahlenther Onkol       Date:  2015-03-08       Impact factor: 3.621

4.  Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study.

Authors:  J S Williamson; D Ingrams; H Jones
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

5.  Gender-specific differences concerning psychosocial aspects and functional impairments that influence quality of life in oral cancer treatment.

Authors:  Philipp Jehn; Sabine Swantje Linsen; Alexander-Nicolai Zeller; Fabian Matthias Eckstein; Michael-Tobias Neuhaus; Nils-Claudius Gellrich; Gertrud Krüskemper; Fritjof Lentge; Simon Spalthoff; Philippe Korn
Journal:  Support Care Cancer       Date:  2022-02-16       Impact factor: 3.603

6.  Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome.

Authors:  E Babin; E Sigston; M Hitier; D Dehesdin; J P Marie; O Choussy
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-11       Impact factor: 2.503

7.  Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.

Authors:  Peter T Dziegielewski; Theodoros N Teknos; Kasim Durmus; Matthew Old; Amit Agrawal; Kiran Kakarala; Anna Marcinow; Enver Ozer
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-11       Impact factor: 6.223

8.  Cine MRI of swallowing in patients with advanced oral or oropharyngeal carcinoma: a feasibility study.

Authors:  Anne Marijn Kreeft; Coen R N Rasch; Sara H Muller; Frank A Pameijer; Eeke Hallo; Alfons J M Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-05       Impact factor: 2.503

9.  Oral cancer malnutrition impacts weight and quality of life.

Authors:  Nils-Claudius Gellrich; Jörg Handschel; Henrik Holtmann; Gertrud Krüskemper
Journal:  Nutrients       Date:  2015-03-27       Impact factor: 5.717

10.  The Impact of Surgery and Radiotherapy on Health-Related Quality of Life of Individuals with Oral and Oropharyngeal Carcinoma and Short-Term Follow up after Treatment.

Authors:  Marcelo Coelho Goiato; Andressa Paschoal Amoroso; Bruna Silva; Emerson Gomes Dos Santos; Fernanda Pereira De Caxias; Sandro Basso Bitencourt; Amalia Moreno; Daniela Micheline Dos Santos
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.